Covered recipient · General Payments record
JAEDA KERIN ERTELT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$720.31
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $191.85 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $38.60 | 2 |
| Esperion Therapeutics, Inc. | $28.90 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $25.82 | 1 |
| Lilly USA, LLC | $23.02 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.48 | 1 |
| ITI, Inc. | $17.35 | 1 |
| Novo Nordisk AS | $14.05 | 1 |
| Alkermes, Inc. | $13.34 | 1 |
| ABBVIE INC. | $13.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.29 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107077538 | CMS |
| Alexion Pharmaceuticals, Inc. | $17.48 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093898422 | CMS |
| Alkermes, Inc. | $13.34 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120495734 | CMS |
| Amgen Inc. | $22.57 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115605282 | CMS |
| Amgen Inc. | $16.03 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115605292 | CMS |
| Boston Scientific Corporation | $25.82 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092547094 | CMS |
| Esperion Therapeutics, Inc. | $13.33 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129465830 | CMS |
| Esperion Therapeutics, Inc. | $15.57 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129465832 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.35 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143441446 | CMS |
| Lilly USA, LLC | $23.02 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135686728 | CMS |
| Novo Nordisk Inc | $14.05 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100444651 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.